EP Wealth Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.18M | Buy |
2,242
+1,209
| +117% | +$635K | 0.01% | 529 |
|
|
2025
Q1 | $655K | Sell |
1,033
-213
| -17% | -$135K | 0.01% | 615 |
|
|
2024
Q4 | $888K | Sell |
1,246
-221
| -15% | -$157K | 0.01% | 534 |
|
|
2024
Q3 | $1.54M | Buy |
1,467
+209
| +17% | +$220K | 0.01% | 408 |
|
|
2024
Q2 | $1.32M | Sell |
1,258
-17
| -1% | -$17.9K | 0.01% | 341 |
|
|
2024
Q1 | $1.23M | Buy |
1,275
+113
| +10% | +$109K | 0.01% | 345 |
|
|
2023
Q4 | $1.02M | Buy |
1,162
+116
| +11% | +$102K | 0.01% | 359 |
|
|
2023
Q3 | $860K | Sell |
1,046
-568,084
| -100% | -$467M | 0.01% | 362 |
|
|
2023
Q2 | $716K | Sell |
569,130
-3,980,870
| -87% | -$5.01M | 0.01% | 388 |
|
|
2023
Q1 | $434K | Buy |
4,550,000
+4,548,780
| +372,851% | +$434K | 0.01% | 426 |
|
|
2022
Q4 | $880K | Buy |
+1,220
| New | +$880K | 0.02% | 298 |
|
|
2022
Q2 | – | Sell |
-306
| Closed | -$214K | – | 683 |
|
|
2022
Q1 | $214K | Buy |
+306
| New | +$214K | ﹤0.01% | 559 |
|
|
2016
Q4 | – | Sell |
-605
| Closed | -$243K | – | 150 |
|
|
2016
Q3 | $243K | Buy |
+605
| New | +$243K | 0.04% | 121 |
|